|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
1 months to Feb 28, 2022
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Loss from operations | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation | |||||
| Amortization of intangible assets | |||||
| Inducement expense | |||||
| Cost of commitment shares issued | |||||
| Change in fair value contingent consideration | |||||
| Loss on equity method investment | |||||
| Prepaid expenses and other current assets | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses and other current assets | |||||
| Accrued expenses | |||||
| Accrued expenses, related party | |||||
| Accounts payable and other current liabilities | |||||
| Net cash used in operating activities – continuing operations | |||||
| Net cash used in discontinued operations | |||||
| Accounts payable, related party | |||||
| Net cash used in operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Purchase consideration received for sale of assets | |||||
| Cash receipt from contingent consideration | |||||
| Net cash provided by investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Net proceeds from sale of common stock | |||||
| Net proceeds from warrant offerings | |||||
| Redemption of fractional shares | |||||
| Net cash provided by financing activities | |||||
| NET INCREASE IN CASH AND CASH EQUIVALENTS | |||||
| CASH AND CASH EQUIVALENTS-BEGINNING OF YEAR | |||||
| CASH AND CASH EQUIVALENTS-END OF YEAR | |||||
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | |||||
| Equity consideration received for sale of Purnovate | |||||
| Issuance of common stock to settle bonus accrual | |||||
Loading...